Role of Glucagon-like Peptide-1 (GLP-1) receptor agonists versus DPP-4 inhibitors for alcohol and substance use disorders in improving HIV-related outcomes and providing health benefits in people living with HIV

Notice ID:75N95026R00007

This is a sources sought notice to identify qualified small businesses capable of conducting a specific pharmacoepidemiological data analysis project for the National Institute on Drug Abuse. The work involves using Veterans Affairs data to study the effects of certain medications on HIV and substance use disorder outcomes. The period of performance is 12 months from award with three 12-month option periods. The data for the project is housed at the VA Connect Medical Center in West Haven, CT. Capable vendors must demonstrate direct access to the required datasets and an already built analysis pipeline.

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NIAID
  PSC   B529 SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
LOCATION: Not Given
Primary Contact
Kimberly Harris
301-***-6391

Links (0)

Attachments (1)


Data sourced from SAM.gov. View Official Posting »